{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:42:36Z","timestamp":1791837756892,"version":"4.3.4"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-024-04484-y","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:07:57Z","timestamp":1740107277000},"page":"8166-8186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Polypharmacology and Neuroprotective Effects of Gingerol in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Sakthi","family":"Priyadarshini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshav","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopashree","family":"R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aatreyi","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritabrata","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehnaz","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alsaweed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohana Vamsi","family":"Nuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosleh Mohammad","family":"Abomughaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmajeed G.","family":"Almutary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra Kumar","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakshu","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. V.","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreesh","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-2502","authenticated-orcid":false,"given":"Vinod Kumar","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-4069","authenticated-orcid":false,"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"4484_CR1","doi-asserted-by":"publisher","unstructured":"Talebi M, \u0130lg\u00fcn S, Ebrahimi V, Talebi M, Farkhondeh T, Ebrahimi H, Samarghandian S (2021) Zingiber officinale ameliorates Alzheimer\u2019s disease and cognitive impairments: lessons from preclinical studies. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 133:111088. https:\/\/doi.org\/10.1016\/j.biopha.2020.111088","DOI":"10.1016\/j.biopha.2020.111088"},{"issue":"6","key":"4484_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/meg.0000000000001730","volume":"32","author":"LA Lucaciu","year":"2020","unstructured":"Lucaciu LA, Seicean R, Seicean A (2020) Small molecule drugs in the treatment of inflammatory bowel diseases: which one, when and why? - a systematic review. Eur J Gastroenterol Hepatol 32(6):669\u2013677. https:\/\/doi.org\/10.1097\/meg.0000000000001730","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4484_CR3","doi-asserted-by":"publisher","unstructured":"Rohini K, Srikumar Padmalayam S (2019) Chapter 13 - Zingiber officinale: antiinflammatory actions and potential usage for arthritic conditions. Academic Press,:233\u2013244. https:\/\/doi.org\/10.1016\/B978-0-12-813820-5.00013-1","DOI":"10.1016\/B978-0-12-813820-5.00013-1"},{"key":"4484_CR4","doi-asserted-by":"publisher","first-page":"5054395","DOI":"10.1155\/2019\/5054395","volume":"2019","author":"NFN Mohd Sahardi","year":"2019","unstructured":"Mohd Sahardi NFN, Makpol S (2019) Ginger (Zingiber officinale Roscoe) in the prevention of ageing and degenerative diseases: review of current evidence. Evid-Based Complement Altern Med\u202f: eCAM 2019:5054395. https:\/\/doi.org\/10.1155\/2019\/5054395","journal-title":"Evid-Based Complement Altern Med : eCAM"},{"key":"4484_CR5","doi-asserted-by":"publisher","first-page":"671058","DOI":"10.1155\/2015\/671058","volume":"2015","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, Arita M, Sakurai H, Ono N, Tezuka Y (2015) Analysis of chemical properties of edible and medicinal ginger by metabolomics approach. Biomed Res Int 2015:671058. https:\/\/doi.org\/10.1155\/2015\/671058","journal-title":"Biomed Res Int"},{"key":"4484_CR6","doi-asserted-by":"publisher","unstructured":"Farombi EO, Abolaji AO, Adetuyi BO, Awosanya O, Fabusoro M (2018) Neuroprotective role of 6-Gingerol-rich fraction of Zingiber officinale (Ginger) against acrylonitrile-induced neurotoxicity in male Wistar rats. Journal of basic and clinical physiology and pharmacology 30 (3). https:\/\/doi.org\/10.1515\/jbcpp-2018-0114","DOI":"10.1515\/jbcpp-2018-0114"},{"issue":"1\u20134","key":"4484_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/biof.552210107","volume":"21","author":"SO Kim","year":"2004","unstructured":"Kim SO, Chun KS, Kundu JK, Surh YJ (2004) Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. BioFactors (Oxford, England) 21(1\u20134):27\u201331. https:\/\/doi.org\/10.1002\/biof.552210107","journal-title":"BioFactors (Oxford, England)"},{"issue":"2","key":"4484_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bbrc.2005.07.076","volume":"335","author":"EC Kim","year":"2005","unstructured":"Kim EC, Min JK, Kim TY, Lee SJ, Yang HO, Han S, Kim YM, Kwon YG (2005) [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 335(2):300\u2013308. https:\/\/doi.org\/10.1016\/j.bbrc.2005.07.076","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4484_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0304-3835(98)00081-0","volume":"129","author":"KK Park","year":"1998","unstructured":"Park KK, Chun KS, Lee JM, Lee SS, Surh YJ (1998) Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 129(2):139\u2013144. https:\/\/doi.org\/10.1016\/s0304-3835(98)00081-0","journal-title":"Cancer Lett"},{"issue":"1\u20132","key":"4484_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ijpharm.2017.11.006","volume":"535","author":"Q Wang","year":"2018","unstructured":"Wang Q, Wei Q, Yang Q, Cao X, Li Q, Shi F, Tong SS, Feng C, Yu Q, Yu J, Xu X (2018) A novel formulation of [6]-gingerol: proliposomes with enhanced oral bioavailability and antitumor effect. Int J Pharm 535(1\u20132):308\u2013315. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.11.006","journal-title":"Int J Pharm"},{"issue":"6","key":"4484_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3892\/br.2024.1773","volume":"20","author":"R Kongsui","year":"2024","unstructured":"Kongsui R, Jittiwat J (2024) In vivo protective effects of 6-gingerol in cerebral ischemia involve preservation of antioxidant defenses and activation of anti-apoptotic pathways. Biomedical reports 20(6):85. https:\/\/doi.org\/10.3892\/br.2024.1773","journal-title":"Biomedical reports"},{"issue":"6","key":"4484_CR12","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s10787-019-00569-6","volume":"27","author":"S Song","year":"2019","unstructured":"Song S, Dang M, Kumar M (2019) Anti-inflammatory and renal protective effect of gingerol in high-fat diet\/streptozotocin-induced diabetic rats via inflammatory mechanism. Inflammopharmacology 27(6):1243\u20131254. https:\/\/doi.org\/10.1007\/s10787-019-00569-6","journal-title":"Inflammopharmacology"},{"key":"4484_CR13","doi-asserted-by":"publisher","unstructured":"Han X, Qi J, Yang Y, Zheng B, Liu M, Liu Y, Li L, Guan S, Jia Q, Chu L (2022) Protective mechanisms of 10-gingerol against myocardial ischemia may involve activation of JAK2\/STAT3 pathway and regulation of Ca(2+) homeostasis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 151:113082. https:\/\/doi.org\/10.1016\/j.biopha.2022.113082","DOI":"10.1016\/j.biopha.2022.113082"},{"key":"4484_CR14","doi-asserted-by":"publisher","first-page":"101034","DOI":"10.1016\/j.jafr.2024.101034","volume":"15","author":"H Azar","year":"2024","unstructured":"Azar H, Mohaddeseh Sadat A, Mitra TJ, Amirhossein S (2024) 6-Gingerol, an ingredient of Zingiber officinale, abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing oxidative stress and inflammation. Journal of Agriculture and Food Research 15:101034. https:\/\/doi.org\/10.1016\/j.jafr.2024.101034","journal-title":"Journal of Agriculture and Food Research"},{"key":"4484_CR15","doi-asserted-by":"publisher","first-page":"779352","DOI":"10.3389\/fphar.2021.779352","volume":"12","author":"JO Unuofin","year":"2021","unstructured":"Unuofin JO, Masuku NP, Paimo OK, Lebelo SL (2021) Ginger from farmyard to town: nutritional and pharmacological applications. Front Pharmacol 12:779352. https:\/\/doi.org\/10.3389\/fphar.2021.779352","journal-title":"Front Pharmacol"},{"issue":"48","key":"4484_CR16","doi-asserted-by":"publisher","first-page":"78281","DOI":"10.18632\/oncotarget.12930","volume":"7","author":"VK Nelson","year":"2016","unstructured":"Nelson VK, Ali A, Dutta N, Ghosh S, Jana M, Ganguli A, Komarov A, Paul S, Dwivedi V, Chatterjee S, Jana NR, Lakhotia SC, Chakrabarti G, Misra AK, Mandal SC, Pal M (2016) Azadiradione ameliorates polyglutamine expansion disease in Drosophila by potentiating DNA binding activity of heat shock factor 1. Oncotarget 7(48):78281\u201378296. https:\/\/doi.org\/10.18632\/oncotarget.12930","journal-title":"Oncotarget"},{"issue":"4","key":"4484_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4103\/2231-4040.104709","volume":"3","author":"C Veeresham","year":"2012","unstructured":"Veeresham C (2012) Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res 3(4):200\u2013201. https:\/\/doi.org\/10.4103\/2231-4040.104709","journal-title":"J Adv Pharm Technol Res"},{"issue":"3","key":"4484_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s13237-022-00405-3","volume":"65","author":"N Nasim","year":"2022","unstructured":"Nasim N, Sandeep IS, Mohanty S (2022) Plant-derived natural products for drug discovery: current approaches and prospects. Nucleus\u202f: Int J Cytol Allied Top 65(3):399\u2013411. https:\/\/doi.org\/10.1007\/s13237-022-00405-3","journal-title":"Nucleus : Int J Cytol Allied Top"},{"key":"4484_CR19","doi-asserted-by":"publisher","unstructured":"Victor Antony Santiago J, Sundari, Karthikkumar V, Partiban S (2017) Chapter 21 - Zingerone (ginger extract): antioxidant potential for efficacy in gastrointestinal and liver disease. Acadenic press:289\u2013297. https:\/\/doi.org\/10.1016\/B978-0-12-805377-5.00021-7","DOI":"10.1016\/B978-0-12-805377-5.00021-7"},{"key":"4484_CR20","doi-asserted-by":"publisher","unstructured":"Habtemariam S (2019) The chemical and pharmacological basis of ginger (Zingiber officinale Roscoe) as potential therapy for diabetes and metabolic syndrome. Academic press:639\u2013687. https:\/\/doi.org\/10.1016\/B978-0-08-102922-0.00018-3","DOI":"10.1016\/B978-0-08-102922-0.00018-3"},{"key":"4484_CR21","doi-asserted-by":"publisher","unstructured":"Victor Antony Santiago J, Sundari, Karthikkumar V, Partiban S (2017) Chapter 21 - Zingerone (ginger extract): antioxidant potential for efficacy in gastrointestinal and liver disease. Academic press:289\u2013297. https:\/\/doi.org\/10.1016\/B978-0-12-805377-5.00021-7","DOI":"10.1016\/B978-0-12-805377-5.00021-7"},{"key":"4484_CR22","doi-asserted-by":"publisher","unstructured":"Solomon H (2019) Chapter 18 - The chemical and pharmacological basis of ginger (Zingiber officinale Roscoe) as potential therapy for diabetes and metabolic syndrome. Academic press:639\u2013687. https:\/\/doi.org\/10.1016\/B978-0-08-102922-0.00018-3","DOI":"10.1016\/B978-0-08-102922-0.00018-3"},{"key":"4484_CR23","doi-asserted-by":"publisher","unstructured":"Zhang M, Zhao R, Wang D, Wang L, Zhang Q, Wei S, Lu F, Peng W, Wu C (2021) Ginger (Zingiber officinale Rosc.) and its bioactive components are potential resources for health beneficial agents. Phytotherapy research : PTR 35 (2):711\u2013742. https:\/\/doi.org\/10.1002\/ptr.6858","DOI":"10.1002\/ptr.6858"},{"key":"4484_CR24","doi-asserted-by":"publisher","first-page":"809621","DOI":"10.3389\/fnut.2022.809621","volume":"9","author":"R Arcusa","year":"2022","unstructured":"Arcusa R, Villa\u00f1o D, Marhuenda J, Cano M, Cerd\u00e0 B, Zafrilla P (2022) Potential role of ginger (Zingiber officinale Roscoe) in the prevention of neurodegenerative diseases. Front Nutr 9:809621. https:\/\/doi.org\/10.3389\/fnut.2022.809621","journal-title":"Front Nutr"},{"issue":"17","key":"4484_CR25","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1021\/jf400095y","volume":"61","author":"CR Kiran","year":"2013","unstructured":"Kiran CR, Chakka AK, Amma KP, Menon AN, Kumar MM, Venugopalan VV (2013) Influence of cultivar and maturity at harvest on the essential oil composition, oleoresin and [6]-gingerol contents in fresh ginger from northeast India. J Agric Food Chem 61(17):4145\u20134154. https:\/\/doi.org\/10.1021\/jf400095y","journal-title":"J Agric Food Chem"},{"key":"4484_CR26","doi-asserted-by":"crossref","unstructured":"Denniff P, Macleod I, Whiting DAJJotCS, Perkin Transactions 1 (1980) Studies in the biosynthesis of [6]-gingerol, pungent principle of ginger (Zingiber officinale). Journal of the Chemical Society (0):2637\u20132644","DOI":"10.1039\/p19800002637"},{"issue":"8","key":"4484_CR27","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1158\/1055-9965.Epi-07-2934","volume":"17","author":"SM Zick","year":"2008","unstructured":"Zick SM, Djuric Z, Ruffin MT, Litzinger AJ, Normolle DP, Alrawi S, Feng MR, Brenner DE (2008) Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomark Prev\u202f: Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 17(8):1930\u20131936. https:\/\/doi.org\/10.1158\/1055-9965.Epi-07-2934","journal-title":"Cancer Epidemiol Biomark Prev : Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"issue":"2","key":"4484_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jep.2009.10.004","volume":"127","author":"S Dugasani","year":"2010","unstructured":"Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S, Korlakunta JN (2010) Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. J Ethnopharmacol 127(2):515\u2013520. https:\/\/doi.org\/10.1016\/j.jep.2009.10.004","journal-title":"J Ethnopharmacol"},{"issue":"23","key":"4484_CR29","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.1021\/jf062235l","volume":"54","author":"E Pfeiffer","year":"2006","unstructured":"Pfeiffer E, Heuschmid FF, Kranz S, Metzler M (2006) Microsomal hydroxylation and glucuronidation of [6]-gingerol. J Agric Food Chem 54(23):8769\u20138774. https:\/\/doi.org\/10.1021\/jf062235l","journal-title":"J Agric Food Chem"},{"key":"4484_CR30","doi-asserted-by":"publisher","first-page":"112820","DOI":"10.1016\/j.jpba.2019.112820","volume":"177","author":"A Simon","year":"2020","unstructured":"Simon A, Darcsi A, K\u00e9ry \u00c1, Riethm\u00fcller E (2020) Blood-brain barrier permeability study of ginger constituents. J Pharm Biomed Anal 177:112820. https:\/\/doi.org\/10.1016\/j.jpba.2019.112820","journal-title":"J Pharm Biomed Anal"},{"key":"4484_CR31","doi-asserted-by":"publisher","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. molecules (Basel, Switzerland) 25 (24). https:\/\/doi.org\/10.3390\/molecules25245789","DOI":"10.3390\/molecules25245789"},{"issue":"10043","key":"4484_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer\u2019s disease. Lancet (London, England) 388(10043):505\u2013517. https:\/\/doi.org\/10.1016\/s0140-6736(15)01124-1","journal-title":"Lancet (London, England)"},{"key":"4484_CR33","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016 (2019). Lancet Neurol 18 (1):88\u2013106. https:\/\/doi.org\/10.1016\/s1474-4422(18)30403-4","DOI":"10.1016\/s1474-4422(18)30403-4"},{"key":"4484_CR34","doi-asserted-by":"publisher","unstructured":"Chauhan P, Wadhwa K, Singh G (2022) Caenorhabditis elegans as a model system to evaluate neuroprotective potential of nano formulations. Frontiers Nanotechnol 4. https:\/\/doi.org\/10.3389\/fnano.2022.1018754","DOI":"10.3389\/fnano.2022.1018754"},{"key":"4484_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnins.2018.00037","volume":"12","author":"RL Frozza","year":"2018","unstructured":"Frozza RL, Lourenco MV, De Felice FG (2018) Challenges for Alzheimer\u2019s disease therapy: insights from novel mechanisms beyond memory defects. Front Neurosci 12:37. https:\/\/doi.org\/10.3389\/fnins.2018.00037","journal-title":"Front Neurosci"},{"key":"4484_CR36","doi-asserted-by":"publisher","unstructured":"Wadhwa K, Pahwa R, Kumar M, Kumar S, Sharma PC, Singh G, Verma R, Mittal V, Singh I, Kaushik D, Jeandet P (2022) Mechanistic insights into the pharmacological significance of silymarin. Molecules (Basel, Switzerland) 27 (16). https:\/\/doi.org\/10.3390\/molecules27165327","DOI":"10.3390\/molecules27165327"},{"issue":"7266","key":"4484_CR37","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/461895a","volume":"461","author":"L Mucke","year":"2009","unstructured":"Mucke L (2009) Neuroscience: Alzheimer\u2019s disease. Nature 461(7266):895\u2013897. https:\/\/doi.org\/10.1038\/461895a","journal-title":"Nature"},{"issue":"2","key":"4484_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A, Ekavali, (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacological reports\u202f: PR 67(2):195\u2013203. https:\/\/doi.org\/10.1016\/j.pharep.2014.09.004","journal-title":"Pharmacological reports : PR"},{"key":"4484_CR39","doi-asserted-by":"publisher","first-page":"109516","DOI":"10.1016\/j.mehy.2019.109516","volume":"136","author":"A Offringa-Hup","year":"2020","unstructured":"Offringa-Hup A (2020) Alzheimer\u2019s disease: the derailed repair hypothesis. Med Hypotheses 136:109516. https:\/\/doi.org\/10.1016\/j.mehy.2019.109516","journal-title":"Med Hypotheses"},{"issue":"1\u20132","key":"4484_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jns.2012.12.013","volume":"333","author":"D Galimberti","year":"2013","unstructured":"Galimberti D, Ghezzi L, Scarpini E (2013) Immunotherapy against amyloid pathology in Alzheimer\u2019s disease. J Neurol Sci 333(1\u20132):50\u201354. https:\/\/doi.org\/10.1016\/j.jns.2012.12.013","journal-title":"J Neurol Sci"},{"issue":"7","key":"4484_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/1533317517717013","volume":"32","author":"A Hosseinkhani","year":"2017","unstructured":"Hosseinkhani A, Sahragard A, Namdari A, Zarshenas MM (2017) Botanical sources for Alzheimer\u2019s: a review on reports from traditional Persian medicine. Am J Alzheimer\u2019s Dis Other Dementias 32(7):429\u2013437. https:\/\/doi.org\/10.1177\/1533317517717013","journal-title":"Am J Alzheimer\u2019s Dis Other Dementias"},{"issue":"2","key":"4484_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.14336\/ad.2018.0328","volume":"10","author":"SG Jeon","year":"2019","unstructured":"Jeon SG, Song EJ, Lee D, Park J, Nam Y, Kim JI, Moon M (2019) Traditional oriental medicines and Alzheimer\u2019s disease. Aging Dis 10(2):307\u2013328. https:\/\/doi.org\/10.14336\/ad.2018.0328","journal-title":"Aging Dis"},{"issue":"4","key":"4484_CR43","first-page":"215","volume":"3","author":"F Dabaghian","year":"2017","unstructured":"Dabaghian F, Azadi A, Setooni M, Zarshenas MMJTIPS (2017) An overview on multi-ingredient memory enhancers and anti-Alzheimer\u2019s formulations from traditional Persian pharmacy. Trends Pharm Sci 3(4):215\u2013220","journal-title":"Trends Pharm Sci"},{"key":"4484_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jep.2018.02.032","volume":"219","author":"M Shelar","year":"2018","unstructured":"Shelar M, Nanaware S, Arulmozhi S, Lohidasan S, Mahadik K (2018) Validation of ethnopharmacology of ayurvedic sarasvata ghrita and comparative evaluation of its neuroprotective effect with modern alcoholic and lipid based extracts in \u03b2-amyloid induced memory impairment. J Ethnopharmacol 219:182\u2013194. https:\/\/doi.org\/10.1016\/j.jep.2018.02.032","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"4484_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/rej.2014.1657","volume":"18","author":"GF Zeng","year":"2015","unstructured":"Zeng GF, Zong SH, Zhang ZY, Fu SW, Li KK, Fang Y, Lu L, Xiao DQ (2015) The role of 6-gingerol on inhibiting amyloid \u03b2 protein-induced apoptosis in PC12 cells. Rejuvenation Res 18(5):413\u2013421. https:\/\/doi.org\/10.1089\/rej.2014.1657","journal-title":"Rejuvenation Res"},{"key":"4484_CR46","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.2147\/dddt.S67778","volume":"8","author":"F Azam","year":"2014","unstructured":"Azam F, Amer AM, Abulifa AR, Elzwawi MM (2014) Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer\u2019s drugs: a computational investigation. Drug Des Dev Ther 8:2045\u20132059. https:\/\/doi.org\/10.2147\/dddt.S67778","journal-title":"Drug Des Dev Ther"},{"key":"4484_CR47","doi-asserted-by":"publisher","unstructured":"Hosseini A, Mirazi N (2014) Memory enhancement by administration of ginger (Zingiber officinale) extract on morphine-induced memory impairment in male rats. J Acute Disease 3. https:\/\/doi.org\/10.1016\/S2221-6189(14)60047-0","DOI":"10.1016\/S2221-6189(14)60047-0"},{"issue":"2","key":"4484_CR48","first-page":"35","volume":"2","author":"A Hosseini","year":"2016","unstructured":"Hosseini A, Gomar A, Mirazi N, Gomar MJAHM (2016) Ameliorating the effect of Zingiber officinale (ginger) hydroethanolic extract on scopolamine-induced memory impairment in adult male rats. Adv Herbal Med 2(2):35\u201342","journal-title":"Adv Herbal Med"},{"issue":"3","key":"4484_CR49","first-page":"105","volume":"2","author":"A Gomar","year":"2015","unstructured":"Gomar A, Hosseini A, Mirazi N, Gomar MJICNJ (2015) Effect of Zingiber officinale (ginger rhizomes) hydroethanolic extract on hyoscine-induced memory impairment in adult male rats. Int Clin Neurosci J 2(3):105\u2013110","journal-title":"Int Clin Neurosci J"},{"key":"4484_CR50","doi-asserted-by":"publisher","unstructured":"Kongsui R, Sriraksa N, Thongrong S (2020) The neuroprotective effect of Zingiber cassumunar Roxb. extract on LPS-induced neuronal cell loss and astroglial activation within the hippocampus. BioMed Res Int 2020:4259316. https:\/\/doi.org\/10.1155\/2020\/4259316","DOI":"10.1155\/2020\/4259316"},{"issue":"1","key":"4484_CR51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1039\/c7fo01149k","volume":"9","author":"E Huh","year":"2018","unstructured":"Huh E, Lim S, Kim HG, Ha SK, Park HY, Huh Y, Oh MS (2018) Ginger fermented with Schizosaccharomyces pombe alleviates memory impairment via protecting hippocampal neuronal cells in amyloid beta(1\u201342) plaque injected mice. Food Funct 9(1):171\u2013178. https:\/\/doi.org\/10.1039\/c7fo01149k","journal-title":"Food Funct"},{"key":"4484_CR52","first-page":"1129","volume":"4","author":"A Pal","year":"2013","unstructured":"Pal A, Miller J, Mishra S (2013) Nootropic activity of Zingiber officinale in albino mice: A behavioral and neurochemical approach. Res J Pharm, Biol Chem Sci 4:1129\u20131138","journal-title":"Res J Pharm, Biol Chem Sci"},{"key":"4484_CR53","doi-asserted-by":"publisher","first-page":"5160293","DOI":"10.1155\/2019\/5160293","volume":"2019","author":"JE Kim","year":"2019","unstructured":"Kim JE, Shrestha AC, Kim HS, Ham HN, Kim JH, Kim YJ, Noh YJ, Kim SJ, Kim DK, Jo HK, Kim DS, Moon KH, Lee JH, Jeong KO, Leem JY (2019) WS-5 extract of Curcuma longa, Chaenomeles sinensis, and Zingiber officinale contains anti-AChE compounds and improves \u03b2-amyloid-induced memory impairment in mice. Evid-Based Complement Altern Med\u202f: eCAM 2019:5160293. https:\/\/doi.org\/10.1155\/2019\/5160293","journal-title":"Evid-Based Complement Altern Med : eCAM"},{"key":"4484_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharmthera.2017.08.010","volume":"182","author":"JG Choi","year":"2018","unstructured":"Choi JG, Kim SY, Jeong M, Oh MS (2018) Pharmacotherapeutic potential of ginger and its compounds in age-related neurological disorders. Pharmacol Ther 182:56\u201369. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.08.010","journal-title":"Pharmacol Ther"},{"key":"4484_CR55","doi-asserted-by":"publisher","first-page":"173974","DOI":"10.1016\/j.ejphar.2021.173974","volume":"898","author":"T Noori","year":"2021","unstructured":"Noori T, Dehpour AR, Sureda A, Sobarzo-Sanchez E, Shirooie S (2021) Role of natural products for the treatment of Alzheimer\u2019s disease. Eur J Pharmacol 898:173974. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173974","journal-title":"Eur J Pharmacol"},{"key":"4484_CR56","doi-asserted-by":"publisher","first-page":"8174345","DOI":"10.1155\/2018\/8174345","volume":"2018","author":"M Zheng","year":"2018","unstructured":"Zheng M, Xin Y, Li Y, Xu F, Xi X, Guo H, Cui X, Cao H, Zhang X, Han C (2018) Ginsenosides: a potential neuroprotective agent. Biomed Res Int 2018:8174345. https:\/\/doi.org\/10.1155\/2018\/8174345","journal-title":"Biomed Res Int"},{"key":"4484_CR57","doi-asserted-by":"crossref","unstructured":"Azam FJNeopind (2017) Ginger components as anti\u2010Alzheimer drugs: focus on drug design. Wiley Online Library:149\u2013166","DOI":"10.1002\/9781119155195.ch7"},{"key":"4484_CR58","doi-asserted-by":"publisher","unstructured":"Schepici G, Contestabile V, Valeri A, Mazzon E (2021) Ginger, a possible candidate for the treatment of dementias? Molecules (Basel, Switzerland) 26 (18). https:\/\/doi.org\/10.3390\/molecules26185700","DOI":"10.3390\/molecules26185700"},{"key":"4484_CR59","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fnagi.2017.00168","volume":"9","author":"M Ayaz","year":"2017","unstructured":"Ayaz M, Sadiq A, Junaid M, Ullah F, Subhan F, Ahmed J (2017) Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants. Front Aging Neurosci 9:168. https:\/\/doi.org\/10.3389\/fnagi.2017.00168","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"4484_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1089\/rej.2012.1389","volume":"16","author":"GF Zeng","year":"2013","unstructured":"Zeng GF, Zhang ZY, Lu L, Xiao DQ, Zong SH, He JM (2013) Protective effects of ginger root extract on Alzheimer disease-induced behavioral dysfunction in rats. Rejuvenation Res 16(2):124\u2013133. https:\/\/doi.org\/10.1089\/rej.2012.1389","journal-title":"Rejuvenation Res"},{"issue":"10","key":"4484_CR61","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jnutbio.2014.05.009","volume":"25","author":"S Lim","year":"2014","unstructured":"Lim S, Moon M, Oh H, Kim HG, Kim SY, Oh MS (2014) Ginger improves cognitive function via NGF-induced ERK\/CREB activation in the hippocampus of the mouse. J Nutr Biochem 25(10):1058\u20131065. https:\/\/doi.org\/10.1016\/j.jnutbio.2014.05.009","journal-title":"J Nutr Biochem"},{"issue":"1","key":"4484_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2014.04.121","volume":"449","author":"M Moon","year":"2014","unstructured":"Moon M, Kim HG, Choi JG, Oh H, Lee PK, Ha SK, Kim SY, Park Y, Huh Y, Oh MS (2014) 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia. Biochem Biophys Res Commun 449(1):8\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.121","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"4484_CR63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/1565","volume":"1","author":"J Hardy","year":"1998","unstructured":"Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (1998) Genetic dissection of Alzheimer\u2019s disease and related dementias: amyloid and its relationship to tau. Nat Neurosci 1(5):355\u2013358. https:\/\/doi.org\/10.1038\/1565","journal-title":"Nat Neurosci"},{"issue":"6","key":"4484_CR64","first-page":"606","volume":"52","author":"M Mathew","year":"2014","unstructured":"Mathew M, Subramanian S (2014) In vitro evaluation of anti-Alzheimer effects of dry ginger (Zingiber officinale Roscoe) extract. Indian J Exp Biol 52(6):606\u2013612","journal-title":"Indian J Exp Biol"},{"issue":"1","key":"4484_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11418-014-0859-3","volume":"69","author":"K Murata","year":"2015","unstructured":"Murata K, Matsumura S, Yoshioka Y, Ueno Y, Matsuda H (2015) Screening of \u03b2-secretase and acetylcholinesterase inhibitors from plant resources. J Nat Med 69(1):123\u2013129. https:\/\/doi.org\/10.1007\/s11418-014-0859-3","journal-title":"J Nat Med"},{"issue":"1","key":"4484_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3233\/jad-150839","volume":"50","author":"S Lim","year":"2016","unstructured":"Lim S, Choi JG, Moon M, Kim HG, Lee W, Bak HR, Sung H, Park CH, Kim SY, Oh MS (2016) An optimized combination of ginger and peony root effectively inhibits amyloid-\u03b2 accumulation and amyloid-\u03b2-mediated pathology in A\u03b2PP\/PS1 double-transgenic mice. J Alzheim Dis\u202f: JAD 50(1):189\u2013200. https:\/\/doi.org\/10.3233\/jad-150839","journal-title":"J Alzheim Dis : JAD"},{"issue":"4","key":"4484_CR67","doi-asserted-by":"publisher","first-page":"e13660","DOI":"10.1111\/jfbc.13660","volume":"45","author":"BO Adetuyi","year":"2021","unstructured":"Adetuyi BO, Farombi EO (2021) 6-Gingerol, an active constituent of ginger, attenuates lipopolysaccharide-induced oxidation, inflammation, cognitive deficits, neuroplasticity, and amyloidogenesis in rat. J Food Biochem 45(4):e13660. https:\/\/doi.org\/10.1111\/jfbc.13660","journal-title":"J Food Biochem"},{"issue":"1","key":"4484_CR68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbrc.2016.06.026","volume":"477","author":"JY Na","year":"2016","unstructured":"Na JY, Song K, Lee JW, Kim S, Kwon J (2016) 6-Shogaol has anti-amyloidogenic activity and ameliorates Alzheimer\u2019s disease via CysLT1R-mediated inhibition of cathepsin B. Biochem Biophys Res Commun 477(1):96\u2013102. https:\/\/doi.org\/10.1016\/j.bbrc.2016.06.026","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"4484_CR69","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbrc.2017.02.029","volume":"484","author":"JY Na","year":"2017","unstructured":"Na JY, Song K, Lee JW, Kim S, Kwon J (2017) Sortilin-related receptor 1 interacts with amyloid precursor protein and is activated by 6-shogaol, leading to inhibition of the amyloidogenic pathway. Biochem Biophys Res Commun 484(4):890\u2013895. https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.029","journal-title":"Biochem Biophys Res Commun"},{"key":"4484_CR70","doi-asserted-by":"crossref","unstructured":"Akhondzadeh S, Abbasi SHJAJoAsD, Dementias\u00ae O (2006) Herbal medicine in the treatment of Alzheimer\u2019s disease. Am J Alzheim Disease & Other Dementias\u00ae, 21 (2):113\u2013118","DOI":"10.1177\/153331750602100211"},{"key":"4484_CR71","first-page":"735","volume":"6","author":"MM Fathy","year":"2015","unstructured":"Fathy MM, Eid H, Hussein MA, Ahmed HH, Hussein A (2015) The role of Zingiber officinale in the treatment of Alzheimer\u2019s disease: in-vitro and in-vivo evidences. Res J Pharm, Biol Chem Sci 6:735\u2013749","journal-title":"Res J Pharm, Biol Chem Sci"},{"issue":"4","key":"4484_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.etp.2010.09.004","volume":"64","author":"G Oboh","year":"2012","unstructured":"Oboh G, Ademiluyi AO, Akinyemi AJ (2012) Inhibition of acetylcholinesterase activities and some pro-oxidant induced lipid peroxidation in rat brain by two varieties of ginger (Zingiber officinale). Exp Toxicol Pathol\u202f: Off J Gesellschaft fur Toxikologische Pathologie 64(4):315\u2013319. https:\/\/doi.org\/10.1016\/j.etp.2010.09.004","journal-title":"Exp Toxicol Pathol : Off J Gesellschaft fur Toxikologische Pathologie"},{"issue":"5","key":"4484_CR73","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.fct.2012.02.014","volume":"50","author":"S Shim","year":"2012","unstructured":"Shim S, Kwon J (2012) Effects of [6]-shogaol on cholinergic signaling in HT22 cells following neuronal damage induced by hydrogen peroxide. Food Chem Toxicol\u202f: Int J Pub British Ind Biol Res Assoc 50(5):1454\u20131459. https:\/\/doi.org\/10.1016\/j.fct.2012.02.014","journal-title":"Food Chem Toxicol : Int J Pub British Ind Biol Res Assoc"},{"issue":"14","key":"4484_CR74","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1080\/07391102.2017.1401004","volume":"36","author":"T Cuya","year":"2018","unstructured":"Cuya T, Baptista L, Celmar Costa Fran\u00e7a T (2018) A molecular dynamics study of components of the ginger (Zingiber officinale) extract inside human acetylcholinesterase: implications for Alzheimer disease. J Biomol Struct Dyn 36(14):3843\u20133855. https:\/\/doi.org\/10.1080\/07391102.2017.1401004","journal-title":"J Biomol Struct Dyn"},{"key":"4484_CR75","doi-asserted-by":"publisher","unstructured":"Tung BT, Thu DK, Thu NTK, Hai NT (2017) Antioxidant and acetylcholinesterase inhibitory activities of ginger root (Zingiber officinale Roscoe) extract. Journal of complementary & integrative medicine 14 (4). https:\/\/doi.org\/10.1515\/jcim-2016-0116","DOI":"10.1515\/jcim-2016-0116"},{"issue":"1","key":"4484_CR76","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3892\/mmr.2016.5244","volume":"14","author":"YX Chen","year":"2016","unstructured":"Chen YX, Li GZ, Zhang B, Xia ZY, Zhang M (2016) Molecular evaluation of herbal compounds as potent inhibitors of acetylcholinesterase for the treatment of Alzheimer\u2019s disease. Mol Med Rep 14(1):446\u2013452. https:\/\/doi.org\/10.3892\/mmr.2016.5244","journal-title":"Mol Med Rep"},{"issue":"2","key":"4484_CR77","first-page":"105","volume":"4","author":"A Gholamhoseinian","year":"2009","unstructured":"Gholamhoseinian A, Moradi MN, Sharifi-Far F (2009) Screening the methanol extracts of some Iranian plants for acetylcholinesterase inhibitory activity. Res Pharm Sci 4(2):105\u2013112","journal-title":"Res Pharm Sci"},{"issue":"10","key":"4484_CR78","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1021\/acsptsci.2c00104","volume":"5","author":"E Angelopoulou","year":"2022","unstructured":"Angelopoulou E, Paudel YN, Papageorgiou SG, Piperi C (2022) Elucidating the beneficial effects of ginger (Zingiber officinale Roscoe) in Parkinson\u2019s disease. ACS Pharmacol Transl Sci 5(10):838\u2013848. https:\/\/doi.org\/10.1021\/acsptsci.2c00104","journal-title":"ACS Pharmacol Transl Sci"},{"key":"4484_CR79","doi-asserted-by":"publisher","unstructured":"Korni F, Khalil F (2017) Effect of ginger and its nanoparticles on growth performance, cognition capability, immunity and prevention of motile Aeromonas septicaemia in Cyprinus carpio fingerlings. Aquaculture Nutrition 23. https:\/\/doi.org\/10.1111\/anu.12526","DOI":"10.1111\/anu.12526"},{"issue":"10","key":"4484_CR80","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1211\/jpp\/60.10.0014","volume":"60","author":"MN Ghayur","year":"2008","unstructured":"Ghayur MN, Gilani AH, Ahmed T, Khalid A, Nawaz SA, Agbedahunsi JM, Choudhary MI, Houghton PJ (2008) Muscarinic, Ca(++) antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia. J Pharm Pharmacol 60(10):1375\u20131383. https:\/\/doi.org\/10.1211\/jpp\/60.10.0014","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"4484_CR81","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.freeradbiomed.2008.04.022","volume":"45","author":"JA Sonnen","year":"2008","unstructured":"Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ (2008) Free radical-mediated damage to brain in Alzheimer\u2019s disease and its transgenic mouse models. Free Radical Biol Med 45(3):219\u2013230. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.04.022","journal-title":"Free Radical Biol Med"},{"issue":"6","key":"4484_CR82","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.fct.2011.03.005","volume":"49","author":"C Lee","year":"2011","unstructured":"Lee C, Park GH, Kim CY, Jang JH (2011) [6]-Gingerol attenuates \u03b2-amyloid-induced oxidative cell death via fortifying cellular antioxidant defense system. Food Chemical Toxicol\u202f: Int J Pub British Ind Biol Res Assoc 49(6):1261\u20131269. https:\/\/doi.org\/10.1016\/j.fct.2011.03.005","journal-title":"Food Chemical Toxicol : Int J Pub British Ind Biol Res Assoc"},{"key":"4484_CR83","doi-asserted-by":"publisher","first-page":"262","DOI":"10.26538\/tjnpr\/v1i6.8","volume":"1","author":"V Vadivel","year":"2017","unstructured":"Vadivel V, Kausalya J, Vidhyalakshmi S, Sriram S, Perumal R, Brindha P (2017) Phytochemical levels and antioxidant activity of traditionally processed Indian herbal mixture (Acorus calamus, Curcuma aromatica and Zingiber officinale). Tropical J Nat Prod Res 1:262\u2013269. https:\/\/doi.org\/10.26538\/tjnpr\/v1i6.8","journal-title":"Tropical J Nat Prod Res"},{"key":"4484_CR84","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1472-6882-13-121","volume":"13","author":"SK Ali","year":"2013","unstructured":"Ali SK, Hamed AR, Soltan MM, Hegazy UM, Elgorashi EE, El-Garf IA, Hussein AA (2013) In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease. BMC Complement Altern Med 13:121. https:\/\/doi.org\/10.1186\/1472-6882-13-121","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"4484_CR85","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jksus.2017.09.015","volume":"30","author":"R Angie","year":"2018","unstructured":"Angie R, Milena F, Luis GS-C, Adriana G, Jos\u00e9 I, Crisp\u00edn AC-Z, Ingrid S, Ludis M (2018) Effect of ginger extract on membrane potential changes and AKT activation on a peroxide-induced oxidative stress cell model. J King Saud Univ - Sci 30(2):263\u2013269. https:\/\/doi.org\/10.1016\/j.jksus.2017.09.015","journal-title":"J King Saud Univ - Sci"},{"key":"4484_CR86","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jchromb.2016.01.009","volume":"1011","author":"Y Li","year":"2016","unstructured":"Li Y, Hong Y, Han Y, Wang Y, Xia L (2016) Chemical characterization and antioxidant activities comparison in fresh, dried, stir-frying and carbonized ginger. J Chromatogr, B: Anal Technol Biomed Life Sci 1011:223\u2013232. https:\/\/doi.org\/10.1016\/j.jchromb.2016.01.009","journal-title":"J Chromatogr, B: Anal Technol Biomed Life Sci"},{"key":"4484_CR87","doi-asserted-by":"publisher","unstructured":"Zhang F, Zhang JG, Yang W, Xu P, Xiao YL, Zhang HT (2018) 6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation. Biomed Pharmacother = Biomed Pharmacotherapie 107:1523\u20131529. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.136","DOI":"10.1016\/j.biopha.2018.08.136"},{"key":"4484_CR88","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.trci.2019.09.009","volume":"5","author":"S Jafarian","year":"2019","unstructured":"Jafarian S, Ling KH, Hassan Z, Perimal-Lewis L, Sulaiman MR, Perimal EK (2019) Effect of zerumbone on scopolamine-induced memory impairment and anxiety-like behaviours in rats. Alzheim Dementia (New York, N Y) 5:637\u2013643. https:\/\/doi.org\/10.1016\/j.trci.2019.09.009","journal-title":"Alzheim Dementia (New York, N Y)"},{"issue":"1","key":"4484_CR89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12974-020-01744-1","volume":"17","author":"L Li","year":"2020","unstructured":"Li L, Wu XH, Zhao XJ, Xu L, Pan CL, Zhang ZY (2020) Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP\/PS1 mice by suppressing MAPK signaling. J Neuroinflammation 17(1):61. https:\/\/doi.org\/10.1186\/s12974-020-01744-1","journal-title":"J Neuroinflammation"},{"issue":"4","key":"4484_CR90","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/s1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer\u2019s disease. The Lancet Neurology 14(4):388\u2013405. https:\/\/doi.org\/10.1016\/s1474-4422(15)70016-5","journal-title":"The Lancet Neurology"},{"issue":"3","key":"4484_CR91","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17(3):157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"4484_CR92","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/acm.2004.10.1009","volume":"10","author":"R Grzanna","year":"2004","unstructured":"Grzanna R, Phan P, Polotsky A, Lindmark L, Frondoza CG (2004) Ginger extract inhibits beta-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Alternat Complement Med (New York, NY) 10(6):1009\u20131013. https:\/\/doi.org\/10.1089\/acm.2004.10.1009","journal-title":"J Alternat Complement Med (New York, NY)"},{"key":"4484_CR93","doi-asserted-by":"publisher","unstructured":"Ho SC, Chang YH (2018) Comparison of Inhibitory Capacities of 6-, 8- and 10-gingerols\/shogaols on the canonical NLRP3 inflammasome-mediated IL-1\u03b2 secretion. Molecules (Basel, Switzerland) 23 (2). https:\/\/doi.org\/10.3390\/molecules23020466","DOI":"10.3390\/molecules23020466"},{"issue":"6","key":"4484_CR94","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1021\/acs.molpharmaceut.9b00246","volume":"16","author":"X Chen","year":"2019","unstructured":"Chen X, Zhou Y, Yu J (2019) Exosome-like nanoparticles from ginger rhizomes inhibited NLRP3 inflammasome activation. Mol Pharm 16(6):2690\u20132699. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00246","journal-title":"Mol Pharm"},{"issue":"6","key":"4484_CR95","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.exger.2010.03.005","volume":"45","author":"MK Kim","year":"2010","unstructured":"Kim MK, Chung SW, Kim DH, Kim JM, Lee EK, Kim JY, Ha YM, Kim YH, No JK, Chung HS, Park KY, Rhee SH, Choi JS, Yu BP, Yokozawa T, Kim YJ, Chung HY (2010) Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway. Exp Gerontol 45(6):419\u2013426. https:\/\/doi.org\/10.1016\/j.exger.2010.03.005","journal-title":"Exp Gerontol"},{"key":"4484_CR96","doi-asserted-by":"publisher","first-page":"100467","DOI":"10.1016\/j.lana.2023.100467","volume":"20","author":"R Brockmann","year":"2023","unstructured":"Brockmann R, Nixon J, Love BL, Yunusa I (2023) Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer\u2019s disease: patient outcomes, healthcare costs, and drug development. Lancet regional health Americas 20:100467. https:\/\/doi.org\/10.1016\/j.lana.2023.100467","journal-title":"Lancet regional health Americas"},{"issue":"5580","key":"4484_CR97","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science (New York, NY) 297(5580):353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994","journal-title":"Science (New York, NY)"},{"issue":"7","key":"4484_CR98","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","volume":"83","author":"J Cummings","year":"2023","unstructured":"Cummings J (2023) Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer\u2019s disease therapeutics. Drugs 83(7):569\u2013576. https:\/\/doi.org\/10.1007\/s40265-023-01858-9","journal-title":"Drugs"},{"issue":"15","key":"4484_CR99","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/wnl.0000000000200176","volume":"98","author":"GS Day","year":"2022","unstructured":"Day GS, Scarmeas N, Dubinsky R, Coerver K, Mostacero A, West B, Wessels SR, Armstrong MJ (2022) Aducanumab use in symptomatic Alzheimer disease evidence in focus: a report of the AAN Guidelines Subcommittee. Neurology 98(15):619\u2013631. https:\/\/doi.org\/10.1212\/wnl.0000000000200176","journal-title":"Neurology"},{"issue":"2","key":"4484_CR100","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, Skordos L, Tian Y, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A (2022) Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheim Dis 9(2):197\u2013210. https:\/\/doi.org\/10.14283\/jpad.2022.30","journal-title":"J Prev Alzheim Dis"},{"key":"4484_CR101","doi-asserted-by":"publisher","first-page":"n1682","DOI":"10.1136\/bmj.n1682","volume":"374","author":"S Walsh","year":"2021","unstructured":"Walsh S, Merrick R, Milne R, Brayne C (2021) Aducanumab for Alzheimer\u2019s disease? BMJ (Clinical research ed) 374:n168210. https:\/\/doi.org\/10.1136\/bmj.n1682","journal-title":"BMJ (Clinical research ed)"},{"issue":"1","key":"4484_CR102","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13024-023-00637-0","volume":"18","author":"VK Ramanan","year":"2023","unstructured":"Ramanan VK, Day GS (2023) Anti-amyloid therapies for Alzheimer disease: finally, good news for patients. Mol Neurodegener 18(1):42. https:\/\/doi.org\/10.1186\/s13024-023-00637-0","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4484_CR103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"issue":"20","key":"4484_CR104","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","volume":"389","author":"RJ Bateman","year":"2023","unstructured":"Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS (2023) Two phase 3 trials of gantenerumab in early Alzheimer\u2019s disease. N Engl J Med 389(20):1862\u20131876. https:\/\/doi.org\/10.1056\/NEJMoa2304430","journal-title":"N Engl J Med"},{"issue":"6","key":"4484_CR105","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM (2023) Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330(6):512\u2013527. https:\/\/doi.org\/10.1001\/jama.2023.13239","journal-title":"JAMA"},{"key":"4484_CR106","doi-asserted-by":"publisher","first-page":"8941564","DOI":"10.1155\/2018\/8941564","volume":"2018","author":"CY Kim","year":"2018","unstructured":"Kim CY, Seo Y, Lee C, Park GH, Jang JH (2018) Neuroprotective effect and molecular mechanism of [6]-gingerol against scopolamine-induced amnesia in C57BL\/6 mice. Evid-Based Complement Alternative Med\u202f: eCAM 2018:8941564. https:\/\/doi.org\/10.1155\/2018\/8941564","journal-title":"Evid-Based Complement Alternative Med : eCAM"},{"issue":"1","key":"4484_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10837450.2018.1558239","volume":"25","author":"L Zhen","year":"2020","unstructured":"Zhen L, Wei Q, Wang Q, Zhang H, Adu-Frimpong M, Kesse Firempong C, Xu X, Yu J (2020) Preparation and in vitro\/in vivo evaluation of 6-Gingerol TPGS\/PEG-PCL polymeric micelles. Pharm Dev Technol 25(1):1\u20138. https:\/\/doi.org\/10.1080\/10837450.2018.1558239","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"4484_CR108","doi-asserted-by":"publisher","first-page":"e22956","DOI":"10.1002\/jbt.22956","volume":"36","author":"FS Rezazadeh-Shojaee","year":"2022","unstructured":"Rezazadeh-Shojaee FS, Ramazani E, Kasaian J, Tayarani-Najaran Z (2022) Protective effects of 6-gingerol on 6-hydroxydopamine-induced apoptosis in PC12 cells through modulation of SAPK\/JNK and survivin activation. J Biochem Mol Toxicol 36(2):e22956. https:\/\/doi.org\/10.1002\/jbt.22956","journal-title":"J Biochem Mol Toxicol"},{"issue":"9","key":"4484_CR109","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson\u2019s disease: A special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord\u202f: Off J Move Disord Soc 32(9):1264\u20131310. https:\/\/doi.org\/10.1002\/mds.27115","journal-title":"Mov Disord : Off J Move Disord Soc"},{"issue":"9","key":"4484_CR110","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/aps.2013.57","volume":"34","author":"G Park","year":"2013","unstructured":"Park G, Kim HG, Ju MS, Ha SK, Park Y, Kim SY, Oh MS (2013) 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson\u2019s disease models via anti-neuroinflammation. Acta Pharmacol Sin 34(9):1131\u20131139. https:\/\/doi.org\/10.1038\/aps.2013.57","journal-title":"Acta Pharmacol Sin"},{"key":"4484_CR111","doi-asserted-by":"publisher","unstructured":"BI Yamout R Alroughani 2018 Multiple sclerosis Seminars in neurology 38 2 212 225 https:\/\/doi.org\/10.1055\/s-0038-1649502","DOI":"10.1055\/s-0038-1649502"},{"key":"4484_CR112","doi-asserted-by":"publisher","first-page":"741503","DOI":"10.3389\/fnins.2021.741503","volume":"15","author":"Z Dworsky-Fried","year":"2021","unstructured":"Dworsky-Fried Z, Chadwick CI, Kerr BJ, Taylor AMW (2021) Multiple sclerosis and the endogenous opioid system. Front Neurosci 15:741503. https:\/\/doi.org\/10.3389\/fnins.2021.741503","journal-title":"Front Neurosci"},{"issue":"2","key":"4484_CR113","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4062\/biomolther.2018.089","volume":"27","author":"A Sapkota","year":"2019","unstructured":"Sapkota A, Park SJ, Choi JW (2019) Neuroprotective effects of 6-shogaol and its metabolite, 6-paradol, in a mouse model of multiple sclerosis. Biomolecules & therapeutics 27(2):152\u2013159. https:\/\/doi.org\/10.4062\/biomolther.2018.089","journal-title":"Biomolecules & therapeutics"},{"issue":"1\u20132","key":"4484_CR114","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2014.08.614","volume":"276","author":"A Jafarzadeh","year":"2014","unstructured":"Jafarzadeh A, Mohammadi-Kordkhayli M, Ahangar-Parvin R, Azizi V, Khoramdel-Azad H, Shamsizadeh A, Ayoobi A, Nemati M, Hassan ZM, Moazeni SM, Khaksari M (2014) Ginger extracts influence the expression of IL-27 and IL-33 in the central nervous system in experimental autoimmune encephalomyelitis and ameliorates the clinical symptoms of disease. J Neuroimmunol 276(1\u20132):80\u201388. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.08.614","journal-title":"J Neuroimmunol"},{"issue":"3","key":"4484_CR115","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/acschemneuro.0c00824","volume":"12","author":"PT Lum","year":"2021","unstructured":"Lum PT, Sekar M, Gan SH, Bonam SR, Shaikh MF (2021) Protective effect of natural products against Huntington\u2019s disease: an overview of scientific evidence and understanding their mechanism of action. ACS Chem Neurosci 12(3):391\u2013418. https:\/\/doi.org\/10.1021\/acschemneuro.0c00824","journal-title":"ACS Chem Neurosci"},{"key":"4484_CR116","doi-asserted-by":"publisher","first-page":"61","DOI":"10.9790\/3013-26206170","volume":"2","author":"M Sharma","year":"2012","unstructured":"Sharma M (2012) Neuroprotective effect of Zingiber officinale in 3-np-induced Huntington disease. IOSR Journal of Pharmacy (IOSRPHR) 2:61\u201370. https:\/\/doi.org\/10.9790\/3013-26206170","journal-title":"IOSR Journal of Pharmacy (IOSRPHR)"},{"issue":"9971","key":"4484_CR117","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/s0140-6736(14)60456-6","volume":"385","author":"SL Mosh\u00e9","year":"2015","unstructured":"Mosh\u00e9 SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet (London, England) 385(9971):884\u2013898. https:\/\/doi.org\/10.1016\/s0140-6736(14)60456-6","journal-title":"Lancet (London, England)"},{"issue":"Suppl 2","key":"4484_CR118","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1111\/j.1528-1157.2000.tb01523.x","volume":"41","author":"RS Greenwood","year":"2000","unstructured":"Greenwood RS (2000) Adverse effects of antiepileptic drugs. Epilepsia 41(Suppl 2):S42-52. https:\/\/doi.org\/10.1111\/j.1528-1157.2000.tb01523.x","journal-title":"Epilepsia"},{"key":"4484_CR119","doi-asserted-by":"publisher","unstructured":"Gawel K, Kukula-Koch W, Banono NS, Nieoczym D, Targowska-Duda KM, Czernicka L, Parada-Turska J, Esguerra CV (2021) 6-Gingerol, a major constituent of Zingiber officinale rhizoma, exerts anticonvulsant activity in the pentylenetetrazole-induced seizure model in larval zebrafish. Int J Mol Sci 22 (14). https:\/\/doi.org\/10.3390\/ijms22147745","DOI":"10.3390\/ijms22147745"},{"issue":"3","key":"4484_CR120","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.eplepsyres.2014.01.008","volume":"108","author":"A Hosseini","year":"2014","unstructured":"Hosseini A, Mirazi N (2014) Acute administration of ginger (Zingiber officinale rhizomes) extract on timed intravenous pentylenetetrazol infusion seizure model in mice. Epilepsy Res 108(3):411\u2013419. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.01.008","journal-title":"Epilepsy Res"},{"issue":"7","key":"4484_CR121","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/1570159x18666200114160844","volume":"18","author":"N Dhir","year":"2020","unstructured":"Dhir N, Medhi B, Prakash A, Goyal MK, Modi M, Mohindra S (2020) Pre-clinical to clinical translational failures and current status of clinical trials in stroke therapy: a brief review. Curr Neuropharmacol 18(7):596\u2013612. https:\/\/doi.org\/10.2174\/1570159x18666200114160844","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"4484_CR122","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1080\/21691401.2019.1606010","volume":"47","author":"C Kang","year":"2019","unstructured":"Kang C, Kang M, Han Y, Zhang T, Quan W, Gao J (2019) 6-Gingerols (6G) reduces hypoxia-induced PC-12 cells apoptosis and autophagy through regulation of miR-103\/BNIP3. Artificial cells, Nanomed Biotechnol 47(1):1653\u20131661. https:\/\/doi.org\/10.1080\/21691401.2019.1606010","journal-title":"Artificial cells, Nanomed Biotechnol"},{"issue":"4","key":"4484_CR123","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/kjm2.12486","volume":"38","author":"Y Zhai","year":"2022","unstructured":"Zhai Y, Liu BG, Mo XN, Zou M, Mei XP, Chen W, Huang GD, Wu L (2022) Gingerol ameliorates neuronal damage induced by hypoxia-reoxygenation via the miR-210\/brain-derived neurotrophic factor axis. Kaohsiung J Med Sci 38(4):367\u2013377. https:\/\/doi.org\/10.1002\/kjm2.12486","journal-title":"Kaohsiung J Med Sci"},{"issue":"4","key":"4484_CR124","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3892\/br.2023.1608","volume":"18","author":"R Kongsui","year":"2023","unstructured":"Kongsui R, Jittiwat J (2023) Ameliorative effects of 6-gingerol in cerebral ischemia are mediated via the activation of antioxidant and anti-inflammatory pathways. Biomedical reports 18(4):26. https:\/\/doi.org\/10.3892\/br.2023.1608","journal-title":"Biomedical reports"},{"key":"4484_CR125","doi-asserted-by":"publisher","first-page":"707772","DOI":"10.3389\/fphar.2021.707772","volume":"12","author":"M Zhao","year":"2021","unstructured":"Zhao M, Yao Y, Du J, Kong L, Zhao T, Wu D, Man L, Zhou W (2021) 6-Gingerol alleviates neonatal hypoxic-ischemic cerebral and white matter injury and contributes to functional recovery. Front Pharmacol 12:707772. https:\/\/doi.org\/10.3389\/fphar.2021.707772","journal-title":"Front Pharmacol"},{"key":"4484_CR126","doi-asserted-by":"publisher","first-page":"173294","DOI":"10.1016\/j.ejphar.2020.173294","volume":"883","author":"Y Liu","year":"2020","unstructured":"Liu Y, Deng S, Zhang Z, Gu Y, Xia S, Bao X, Cao X, Xu Y (2020) 6-Gingerol attenuates microglia-mediated neuroinflammation and ischemic brain injuries through Akt-mTOR-STAT3 signaling pathway. Eur J Pharmacol 883:173294. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173294","journal-title":"Eur J Pharmacol"},{"key":"4484_CR127","doi-asserted-by":"publisher","first-page":"108146","DOI":"10.1016\/j.intimp.2021.108146","volume":"100","author":"J Luo","year":"2021","unstructured":"Luo J, Chen J, Yang C, Tan J, Zhao J, Jiang N, Zhao Y (2021) 6-Gingerol protects against cerebral ischemia\/reperfusion injury by inhibiting NLRP3 inflammasome and apoptosis via TRPV1 \/ FAF1 complex dissociation-mediated autophagy. Int Immunopharmacol 100:108146. https:\/\/doi.org\/10.1016\/j.intimp.2021.108146","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"4484_CR128","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/ptr.4842","volume":"27","author":"JK Jeong","year":"2013","unstructured":"Jeong JK, Moon MH, Park YG, Lee JH, Lee YJ, Seol JW, Park SY (2013) Gingerol-induced hypoxia-inducible factor 1 alpha inhibits human prion peptide-mediated neurotoxicity. Phytother Res\u202f: PTR 27(8):1185\u20131192. https:\/\/doi.org\/10.1002\/ptr.4842","journal-title":"Phytother Res : PTR"},{"key":"4484_CR129","first-page":"109","volume":"2","author":"H Joshi","year":"2006","unstructured":"Joshi H, Parle MJNP (2006) Evaluation of antiamnestic potentials of [6]-gingerol and phyllanthin in mice. Nat Prod Drug Discover 2:109\u2013117","journal-title":"Nat Prod Drug Discover"},{"key":"4484_CR130","doi-asserted-by":"publisher","unstructured":"Anh NH, Kim SJ, Long NP, Min JE, Yoon YC, Lee EG, Kim M, Kim TJ, Yang YY, Son EY, Yoon SJ, Diem NC, Kim HM, Kwon SW (2020) Ginger on human health: a comprehensive systematic review of 109 randomized controlled trials. Nutrients 12 (1). https:\/\/doi.org\/10.3390\/nu12010157","DOI":"10.3390\/nu12010157"},{"issue":"2","key":"4484_CR131","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3109\/19390211.2011.569514","volume":"8","author":"Y Richter","year":"2011","unstructured":"Richter Y, Herzog Y, Eyal I, Cohen T (2011) Cognitex supplementation in elderly adults with memory complaints: an uncontrolled open label trial. J Diet Suppl 8(2):158\u2013168. https:\/\/doi.org\/10.3109\/19390211.2011.569514","journal-title":"J Diet Suppl"},{"key":"4484_CR132","doi-asserted-by":"publisher","first-page":"383062","DOI":"10.1155\/2012\/383062","volume":"2012","author":"N Saenghong","year":"2012","unstructured":"Saenghong N, Wattanathorn J, Muchimapura S, Tongun T, Piyavhatkul N, Banchonglikitkul C, Kajsongkram T (2012) Zingiber officinale improves cognitive function of the middle-aged healthy women. Evid-Based Complement Altern Med\u202f: eCAM 2012:383062. https:\/\/doi.org\/10.1155\/2012\/383062","journal-title":"Evid-Based Complement Altern Med : eCAM"},{"issue":"6","key":"4484_CR133","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ctim.2015.06.009","volume":"23","author":"H Tajadini","year":"2015","unstructured":"Tajadini H, Saifadini R, Choopani R, Mehrabani M, Kamalinejad M, Haghdoost AA (2015) Herbal medicine Davaie Loban in mild to moderate Alzheimer\u2019s disease: a 12-week randomized double-blind placebo-controlled clinical trial. Complement Ther Med 23(6):767\u2013772. https:\/\/doi.org\/10.1016\/j.ctim.2015.06.009","journal-title":"Complement Ther Med"},{"key":"4484_CR134","doi-asserted-by":"publisher","first-page":"4086749","DOI":"10.1155\/2019\/4086749","volume":"2019","author":"H Watari","year":"2019","unstructured":"Watari H, Shimada Y, Matsui M, Tohda C (2019) Kihito, a traditional Japanese Kampo medicine, improves cognitive function in Alzheimer\u2019s disease patients. Evid Based Complement Alternat Med: eCAM 2019:4086749. https:\/\/doi.org\/10.1155\/2019\/4086749","journal-title":"Evid Based Complement Alternat Med: eCAM"},{"key":"4484_CR135","doi-asserted-by":"publisher","unstructured":"Marx W, McCarthy AL, Ried K, McKavanagh D, Vitetta L, Sali A, Lohning A, Isenring E (2017) The effect of a standardized ginger extract on chemotherapy-induced nausea-related quality of life in patients undergoing moderately or highly emetogenic chemotherapy: a double blind, randomized, placebo controlled trial. Nutrients 9 (8). https:\/\/doi.org\/10.3390\/nu9080867","DOI":"10.3390\/nu9080867"},{"issue":"3","key":"4484_CR136","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/1534735417753541","volume":"17","author":"X Li","year":"2018","unstructured":"Li X, Qin Y, Liu W, Zhou XY, Li YN, Wang LY (2018) Efficacy of ginger in ameliorating acute and delayed chemotherapy-induced nausea and vomiting among patients with lung cancer receiving cisplatin-based regimens: a randomized controlled trial. Integr Cancer Ther 17(3):747\u2013754. https:\/\/doi.org\/10.1177\/1534735417753541","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"4484_CR137","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1158\/1940-6207.Capr-12-0327","volume":"6","author":"J Citronberg","year":"2013","unstructured":"Citronberg J, Bostick R, Ahearn T, Turgeon DK, Ruffin MT, Djuric Z, Sen A, Brenner DE, Zick SM (2013) Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prev Res (Phila) 6(4):271\u2013281. https:\/\/doi.org\/10.1158\/1940-6207.Capr-12-0327","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9","key":"4484_CR138","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/mc.22163","volume":"54","author":"SM Zick","year":"2015","unstructured":"Zick SM, Turgeon DK, Ren J, Ruffin MT, Wright BD, Sen A, Djuric Z, Brenner DE (2015) Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer. Mol Carcinog 54(9):908\u2013915. https:\/\/doi.org\/10.1002\/mc.22163","journal-title":"Mol Carcinog"},{"issue":"1","key":"4484_CR139","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ctim.2013.12.015","volume":"22","author":"MA van Tilburg","year":"2014","unstructured":"van Tilburg MA, Palsson OS, Ringel Y, Whitehead WE (2014) Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial. Complement Ther Med 22(1):17\u201320. https:\/\/doi.org\/10.1016\/j.ctim.2013.12.015","journal-title":"Complement Ther Med"},{"issue":"11","key":"4484_CR140","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/s1063-4584(03)00169-9","volume":"11","author":"I Wigler","year":"2003","unstructured":"Wigler I, Grotto I, Caspi D, Yaron M (2003) The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarthritis Cartilage 11(11):783\u2013789. https:\/\/doi.org\/10.1016\/s1063-4584(03)00169-9","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04484-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:03:21Z","timestamp":1751364201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04484-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":140,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4484"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04484-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"17 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}